Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)

This study has been completed.
Information provided by:
PharmaNeuroBoost N.V. Identifier:
First received: May 2, 2008
Last updated: April 29, 2011
Last verified: April 2011